19-norandrostenedione has been researched along with testosterone propionate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diel, P; Friedel, A; Geyer, H; Kamber, M; Laudenbach-Leschowsky, U; Schänzer, W; Schleipen, B; Thevis, M; Vollmer, G; Zierau, O | 1 |
| Bloch, W; Diel, P; Frese, S; Schänzer, W; Schleipen, B; Velders, M | 1 |
2 other study(ies) available for 19-norandrostenedione and testosterone propionate
| Article | Year |
|---|---|
The prohormone 19-norandrostenedione displays selective androgen receptor modulator (SARM) like properties after subcutaneous administration.
Topics: Anabolic Agents; Androgens; Androstenedione; Animals; Injections, Subcutaneous; Liver; Male; Rats; Rats, Wistar; Receptors, Androgen; Testosterone Propionate | 2008 |
Myosin heavy chain expression pattern as a marker for anabolic potency: desoxymethyltestosterone (madol), norandrostenedione and testosterone repress MHC-IIb expression and stimulate MHC-IId/x expression in orchiectomized rat gastrocnemius muscle.
Topics: Anabolic Agents; Androgens; Androstenedione; Androstenols; Animals; Biomarkers; Designer Drugs; Down-Regulation; Hindlimb; Male; Molecular Weight; Muscle Fibers, Skeletal; Muscle, Skeletal; Myosin Heavy Chains; Orchiectomy; Organ Size; Protein Isoforms; Random Allocation; Rats; Rats, Wistar; Testosterone Propionate; Up-Regulation | 2011 |